Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-012791
Filing Date
2025-05-13
Accepted
2025-05-13 17:04:57
Documents
2
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 form3-05132025_090553.html 3  
1 form3-05132025_090553.xml 3 3823
2 ex24-05132025_090553.htm EX-24 3794
  Complete submission text file 0001415889-25-012791.txt   8977
Mailing Address P O BOX 619100 DALLAS TX 752619100
Business Address
FALK THOMAS J (Reporting) CIK: 0001222890 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35565 | Film No.: 25941205

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)